Borderline personality disorder (BPD) affects roughly 1 to 3 out of every 100 adults in the general population, with U.S. community surveys placing the lifetime prevalence at about 2.7%. That makes it one of the more common personality disorders, though it’s far more concentrated in mental health treatment settings than those numbers alone suggest.
Prevalence in the General Population
Across studies, the lifetime prevalence of BPD in the general adult population ranges from 0.7% to 2.7%. The higher end of that range comes from a large U.S. community sample, where 2.7% of individuals had received a BPD diagnosis at some point in their lives. To put that in perspective, if you gathered 100 randomly selected adults, two or three of them would meet criteria for BPD over the course of their lifetimes.
The broader category BPD belongs to, Cluster B personality disorders (which also includes narcissistic and antisocial personality disorder), has a global pooled prevalence of about 2.8%. Rates are notably higher in high-income countries (3.7%) compared to lower- and middle-income countries (1.5%), a pattern that likely reflects both genuine differences and uneven access to mental health diagnosis.
Rates in Psychiatric Settings
BPD is far more common among people already receiving mental health care. About 10% of psychiatric outpatients and 20% of psychiatric inpatients carry a BPD diagnosis. This concentration makes sense: BPD involves intense emotional pain, unstable relationships, and impulsive behavior that frequently drives people to seek help, sometimes in crisis.
Self-harm is a major reason for this overrepresentation. At the time of entering long-term studies, roughly 90% of people with BPD reported self-harming behavior, and as many as 70% had attempted suicide at least once. Between 5% and 10% ultimately die by suicide. These numbers are sobering but also reflect the population most likely to be in treatment. Over time, rates of both self-harm and suicide attempts drop substantially, falling to around 14% for self-harm and 8% for suicide attempts after 16 years of follow-up.
Who Gets Diagnosed: Gender and Bias
For decades, clinical manuals stated that BPD was three times more common in women than men. That 3:1 ratio shaped how the disorder was understood and, in many ways, who got screened for it. But large epidemiological surveys now tell a different story: BPD appears to be roughly equally common in men and women.
So why the longstanding gap? Two forms of bias likely played a role. First, multiple studies have confirmed that clinicians have a subtle tendency to diagnose BPD more readily in women presenting with the same symptoms. Second, and perhaps more important, is where the studies happened. Women with BPD are more likely to engage in self-directed harm that brings them into psychiatric settings, while men with BPD more often develop substance abuse or antisocial behavior that routes them toward addiction treatment or the criminal justice system instead. Studies conducted only in psychiatric hospitals and clinics would naturally find more women.
Racial and Ethnic Differences
BPD does not affect all racial and ethnic groups at the same rate, at least based on U.S. community data. Native Americans report the highest prevalence at about 5.0%, followed by Black Americans at 3.5%. White Americans fall around 2.7%, Hispanic Americans around 2.5%, and Asian Americans have the lowest rate at roughly 1.2%. These differences may reflect a combination of genuine variation, differing exposure to risk factors like childhood adversity, and cultural differences in how emotional distress is expressed or reported.
BPD Peaks in Young Adults
BPD traits are most pronounced in adolescence and early adulthood. Studies consistently show that teenagers and young adults (roughly ages 15 to 30) have significantly higher rates of both BPD traits and formal diagnoses compared to adults over 30. Symptom severity tends to decrease with age, which is one of the more hopeful findings in BPD research. Many people who meet full diagnostic criteria in their twenties no longer do by their thirties or forties.
This trajectory matters because BPD has historically been described as chronic and intractable. The data suggest otherwise for a significant number of people. In one 16-year prospective study, the percentage of participants still engaging in self-harm dropped from over 90% at the start to about 14%, and suicide attempt rates fell from nearly 80% to around 8%. That’s not a disorder that stays frozen in place.
How BPD Is Diagnosed
A BPD diagnosis requires meeting at least 5 of 9 specific criteria that reflect a pattern of instability in emotions, self-image, and relationships, along with marked impulsivity. Those criteria include frantic efforts to avoid abandonment, relationships that swing between idealization and devaluation, an unstable sense of identity, impulsivity in areas like spending or substance use, self-harm or suicidal behavior, rapid mood shifts lasting hours to days, chronic emptiness, intense or poorly controlled anger, and stress-related paranoia or dissociation.
The “5 of 9” threshold means two people with BPD can look very different from each other. One person might primarily struggle with emptiness, identity confusion, and dissociation, while another might present with explosive anger, impulsive behavior, and stormy relationships. This variability contributes to both underdiagnosis and misdiagnosis, particularly when symptoms overlap with depression, bipolar disorder, or anxiety disorders. Anxiety disorders co-occur frequently with BPD: roughly 20% of people with BPD also meet criteria for social phobia, about 23% for adjustment disorders, and around 18% for panic disorder.
The Economic Weight of BPD
BPD carries a heavy financial burden, both for individuals and for healthcare systems. In Germany, where detailed cost analyses have been conducted, the average annual cost per person with BPD was about €31,130 (roughly $34,000) in the year before they entered specialized treatment. More than half of that came from direct healthcare costs, primarily hospital stays. The rest came from indirect costs, with lost work productivity being the single largest driver.
Those per-person costs are dramatically higher than for many other mental health conditions. In the same country using similar methods, the annual cost for a patient with depression was about €7,100 and for alcohol dependence about €11,100. BPD’s costs were roughly three to four times higher, largely because of frequent hospitalizations and the degree to which the disorder disrupts a person’s ability to work consistently.